News

The $4.5 billion would be paid over nine years for prevention, treatment and recovery programs related to opioid addiction.

IRS adds further conditions associated with "historic" PBGC interim rule, which multiemployer plan professionals will want to read carefully.

The 14 largest drug manufacturers paid themselves and investors $578 billion from 2016 to 2020, while investing $522 billion on R&D.

According to USC research: 'It's time to fix incentives in the Medicare Part D system to put the patient first.'

Last year, more than one in 10 uninsured adults experienced mental illness, but only 57% of them received treatment.

Research from Carson Group and Hidden Insights Group reveals the main challenges women face in pursuing this career.